Reaktion #663737

ord-7e80f1ab536a4ee6b3c45c462756e0ae

Reaktionsgleichung

NC(=O)Cl
carbamoyl chloride
C[Si](C)(C)[N-][Si](C)(C)C.[K+]
Potassium bis(trimethylsilyl)amide
O=C([O-])O.[Na+]
Sodium bicarbonate
ClCCl.O=C(O)C(F)(F)F
DCM trifluoroacetic acid
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314
Oxycodone
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314
oxycodone
CN(CCN)C(=O)O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
N-methyl-N-(2-amino)ethylcarbamate-2TFA

Lösungsmittel

Reaktionsbedingungen

Temperatur
-10°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigein dry
  2. 2
    Sonstigedegassed tetrahydrofuran (120 mL)
  3. 3
    workup.STIRRINGThe mixture was stirred at −5° C. for 30 min
  4. 4
    workup.STIRRINGThe reaction was stirred at room temperature for 2 h
  5. 5
    EinengenThe mixture was concentrated in vacuo to half of its initial volume
  6. 6
    workup.ADDITIONEtOAc (50 mL) was added
  7. 7
    Sonstigelayers were separated
  8. 8
    WaschenThe organic phase was further washed with water (3×20 mL), brine (40 mL)
  9. 9
    Einengenwas concentrated
  10. 10
    SonstigeThe residue was purified by silica gel chromatography
  11. 11
    Sonstigeto afford a white foam in 55% yield (7.0 g, 13.4 mmol)
  12. 12
    workup.STIRRINGstirred for 1 h
  13. 13
    EinengenThe solution was then concentrated in vacuo

Vorschrift

Oxycodone free base (6.5 g, 20.6 mmol) was dissolved in dry, degassed tetrahydrofuran (120 mL), and the mixture was cooled to −10° C. using dry ice/acetone bath. Potassium bis(trimethylsilyl)amide (KHMDS) (103.0 mL, 51.6 mmol, 0.5 M in toluene) was added via cannula. The mixture was stirred under N2 at below −5° C. for 30 min. N,N-Bis(tert-butyl)N′-2-(chlorocarbonyl(methyl)amino)ethylcarbamate (8.0 g, 23.7 mmol), (E-8) prepared as described in the Example herein, in THF (30 mL) was then added via cannula over 15 min. The mixture was stirred at −5° C. for 30 min. Another portion of carbamoyl chloride (4.0 g, 11.9 mmol) in THF (10 mL) was added. The reaction was stirred at room temperature for 2 h. Sodium bicarbonate (10 mL, sat. aq.) was added. The mixture was concentrated in vacuo to half of its initial volume. EtOAc (50 mL) was added and layers were separated. The organic phase was further washed with water (3×20 mL), brine (40 mL) and then was concentrated. The residue was purified by silica gel chromatography, using DCM/MeOH (gradient 100/1 to 100/15) to afford a white foam in 55% yield (7.0 g, 13.4 mmol). This material was dissolved in a 1:1 mixture of DCM/trifluoroacetic acid (TFA) (20 mL/20 mL) at room temperature and stirred for 1 h. The solution was then concentrated in vacuo to afford oxycodone 6-(N-methyl-N-(2-amino)ethylcarbamate-2TFA as a thick oil (7.3 g, 11.4 mmol, 99% purity). MS: (m/z) calc: 415.2, observed (M+H+) 416.5. The oxycodone 6-(N-methyl-N-(2-amino)ethylcarbamate-2TFA (E-9) was used without further purification.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09040032B2uspto-grants-2015_05